Minerva Neurosciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | $0.0 | $0.0 | $0.0 | $0.0 |
| Operating income | -$15.1 | -$21.8 | -$23.1 | -$25.2 | -$45.4 |
| Net income | -$293.4 | $1.4 | -$30.0 | -$32.1 | -$49.9 |
| Cash Flow Statement | |||||
| Free cash flow | — | — | — | -$24.7 | — |
Shares outstanding 47.7M · Free float 85.0%
Annual filing data through FY ended December 31, 2025; float as of October 1, 2026.